Faculty profile

Ellen Rafferty

ResearcherUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses and email address may be missing. Find their university profile.

Ellen Rafferty

Researcher

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
20 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Accessibility Children & Youth Health Equity Healthcare Services Immunization Population Health Vaccination Vaccine Coverage

Latest papers

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada.
Pharmacoepidemiology and drug safety · 2026
Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.
PloS one · 2026
Barriers and facilitators for return-to-work following post-COVID-19 condition: A scoping review.
Work (Reading, Mass.) · 2026

All 29 publications

Latest funding

Equity-Informed Evaluation of Expanding Hospital-Based Childhood Vaccination Services
CIHR · 2026 · Principal investigator
$665,552
Vaccination in a pandemic: The impact on routine vaccinations and future COVID-19 vaccine acceptance
CIHR · 2020 · Co-investigator
$334,908
Optimizing adult vaccination outcomes under public health budgetary constraints
CIHR · 2020 · Co-investigator
$139,850

All 3 grants and awards

29 publications.

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada.

Aponte-Hao S, Vu K, Randall JR, Martins KJB, Nguyen PU, Saxinger L, Leal J, Rennert-May E, Rafferty E, Williamson T, Klarenbach SW

Pharmacoepidemiology and drug safety2026

DOI: 10.1002/pds.70302 PMID: 41449712

Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.

Gebretekle GB, Lan M, Xi M, Ximenes R, Buchan SA, Abrams EM, Andrew MK, Brousseau N, Killikelly A, Money D, Papenburg J, Rafferty E, Robinson JL, Siu W, Tunis M, Tuite AR

PloS one2026

DOI: 10.1371/journal.pone.0351183 PMID: 42284362

Barriers and facilitators for return-to-work following post-COVID-19 condition: A scoping review.

Shaver N, Dahroug L, Vyas N, McGuire M, Tahsin A, Adedunye D, Gauthier S, Sterling E, Collins E, Hughes SE, Rafferty AM, Rafferty E, Groot G, Laframboise W, Mann C, Bhereur A, Edwards J, McQuillan R, Theodoratou E, Edjoc R, Little J

Work (Reading, Mass.)2026

DOI: 10.1177/10519815261454982 PMID: 42233731

Vaccination as cost-stabilizing health infrastructure: A Canadian perspective.

Tuite AR, Fisman DN, Rafferty E, Tunis M

Canadian journal of public health = Revue canadienne de sante publique2026

DOI: 10.17269/s41997-026-01222-w PMID: 42303948

The impact of testing positive versus negative for COVID-19 on health-related quality of life: cross-sectional evidence from the Alberta post-COVID-19 follow-up survey

Kirwin E, Adibnia E, Wiggins M, Sander B, Xie F, Ohinmaa A, Johnson JA, Norris C, Rafferty E, MacDonald SE

Quality of Life Research2026

DOI: 10.1007/s11136-026-04174-3

The decision uncertainty toolkit: Risk measures and visual outputs to support decision making during public health crises.

Wiggins M, Varughese M, Rafferty E, van Katwyk S, McCabe C, Round J, Kirwin E

PloS one2025

DOI: 10.1371/journal.pone.0332522 PMID: 41032497

A national curriculum and community of practice for health services and policy research training: Insights from the Health System Impact Fellowship National Cohort Training Program (HSIF NCTP)

Marshall DA, Sidhu S, Oddone Paolucci E, Lopatina E, Gallant N, Manhas KP, McGrail K, Wasylak T, Zelinsky S, Bryan S

Learning Health Systems20252 citations

DOI: 10.1002/lrh2.70025

'My feet cannot stand on their own': podoconiosis patient healthcare expenditures and income impacts in Rwanda.

Schurer JM, Bayisenge U, Hakizimana D, Rafferty E

Transactions of the Royal Society of Tropical Medicine and Hygiene2024Senior author

DOI: 10.1093/trstmh/trae006 PMID: 38456460

Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants.

Gebretekle GB, Yeung MW, Ximenes R, Cernat A, Simmons AE, Killikelly A, Siu W, Rafferty E, Brousseau N, Tunis M, Tuite AR

Vaccine2024

DOI: 10.1016/j.vaccine.2024.126164 PMID: 39079810

Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials.

Tadount F, Kiely M, Assi A, Rafferty E, Sadarangani M, MacDonald SE, Quach C

Open forum infectious diseases2024

DOI: 10.1093/ofid/ofae222 PMID: 38737434

Something wrong or missing on this profile? Suggest a correction

Ellen Rafferty

Research

Latest papers

Latest funding

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada.

Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.

Barriers and facilitators for return-to-work following post-COVID-19 condition: A scoping review.

Vaccination as cost-stabilizing health infrastructure: A Canadian perspective.

The impact of testing positive versus negative for COVID-19 on health-related quality of life: cross-sectional evidence from the Alberta post-COVID-19 follow-up survey

The decision uncertainty toolkit: Risk measures and visual outputs to support decision making during public health crises.

A national curriculum and community of practice for health services and policy research training: Insights from the Health System Impact Fellowship National Cohort Training Program (HSIF NCTP)

'My feet cannot stand on their own': podoconiosis patient healthcare expenditures and income impacts in Rwanda.

Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants.

Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials.

Equity-Informed Evaluation of Expanding Hospital-Based Childhood Vaccination Services

Vaccination in a pandemic: The impact on routine vaccinations and future COVID-19 vaccine acceptance

Optimizing adult vaccination outcomes under public health budgetary constraints

Frequent collaborators

Manish Sadarangani

Caroline Quach

Winnie Siu

Shannon MacDonald

Marcello Tonelli

Marcello Tonelli

Rojiemiahd Edjoc

Christopher McCabe

Brenda Hemmelgarn

Christine Friedenreich

William Ghali

Malcolm Doupe

Julian Little

Verna Yiu

Suzanne Tough

Tyler Williamson

Greta Cummings

Brenda Hemmelgarn

Marcello Tonelli

Deborah Mcneil

Tracy Wasylak

Kathryn Todd

Beate Sander